BROWSE·page 256 of 295

Browse EX-10 agreements

3,536 matching material contract exhibits.


EX-10.1

LyondellBasell Industries N.V.

EXECUTION VERSION

EIGHTH AMENDMENT TO RECEIVABLES PURCHASE AGREEMENT

THIS EIGHTH AMENDMENT TO RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of May 29, 2026 but effective as of June 26, 2026, is entered into among LYB RECEIVABLES LLC, a Delaware limited liability company, as seller (the “Seller”), LYONDELL CHEMICAL COMPANY, a Delaware corporation (“Lyondell Chemical”), as initial servicer (in such capacity, together with its successors and permitted assigns in such capacity, the “Servicer”), the various CONDUIT PURCHASERS, RELATED COMMITTED PURCHASERS, LC PARTICIPANTS and PURCHASER AGENTS party hereto, and MIZUHO BANK, LTD. (“Mizuho”), as issuer of Letters of Credit (in such capacity, together with its successors and assigns in such capacity, the “LC Bank”), and as Administrator (in such capacity, together with its successors and assigns in such capacity, the “Administrator”).

RECITALS

EX-10.1·8-K·CIK 1489393·ACC 0001489393-26-000050·Filed May 29, 2026, 16:15 ET

EXHIBIT 10.1

Edesa Biotech, Inc.

AMENDMENT NO. 5 TO

EDESA BIOTECH, INC.

2019 EQUITY INCENTIVE COMPENSATION PLAN

This Amendment No. 5 to the Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan (this “Amendment”) is made and entered into effective as of March 18, 2026 (the “Effective Date”), by Edesa Biotech, Inc., a British Columbia corporation (the “Company”).

RECITALS

WHEREAS, the Company previously adopted the Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan (the “Plan”);

WHEREAS, by written consent of the Company’s Board of Directors (the “Board”), dated as of the Effective Date, the Board approved an increase in the number of shares of the Company’s Common Shares reserved for issuance under the Plan by 750,000 shares; and

WHEREAS, the Board also approved elimination of the limit on the number of Common Shares that may be awarded as “Options” (as defined by the Plan) to a participant during any calendar year;

EX-10.1·8-K·CIK 1540159·ACC 0001171843-26-003793·Filed May 29, 2026, 16:15 ET

EXHIBIT 10.1

AVIS BUDGET GROUP, INC.

May 26, 2026

Tina Goldenberg

Dear Tina,

I am pleased to confirm your promotion to Vice President & Chief Accounting Officer with Avis Budget Car Rental, LLC (the “Company”), effective June 15, 2026, based at the Company’s headquarters located in Parsippany, New Jersey. In connection with your promotion, you will also serve as Chief Accounting Officer of Avis Budget Group, Inc. This offer and your employment relationship will be subject to the terms and conditions of this letter as well as the Company’s Code of Conduct and other policies, procedures, plans and agreements applicable to your role.

Your salary on an annualized basis will be $270,000 (USD) and paid on a bi-weekly basis. This position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay. Your salary is intended to compensate you for all hours worked. Your work hours may vary from week to week depending on the Company’s needs.

EX-10.1·8-K·CIK 723612·ACC 0000950142-26-001547·Filed May 29, 2026, 16:15 ET

EX-10.2

Enveric Biosciences, Inc.

Exhibit 10.2

RESTRICTED STOCK AWARD AGREEMENT

ENVERIC BIOSCIENCES, INC.

2020 LONG-TERM INCENTIVE PLAN

  1. Grant of Award. Pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the “Plan”) for Employees, Contractors, and Outside Directors of Enveric Biosciences, Inc., a Delaware corporation (the “Company”), the Company grants to

(the “Participant”)

an Award of Restricted Stock in accordance with Section 6.4 of the Plan. The number of shares of Common Stock awarded under this Restricted Stock Award Agreement (the “Agreement”) is ______________ (_______) shares (the “Awarded Shares”). The “Date of Grant” of this Award is ___________________.

EX-10.2·8-K·CIK 890821·ACC 0001493152-26-026364·Filed May 29, 2026, 16:13 ET

EX-10.1

Enveric Biosciences, Inc.

WITH EXECUTIVE EMPLOYMENT AGREEMENT FORM

RESTRICTED STOCK UNIT AWARD AGREEMENT

ENVERIC BIOSCIENCES, INC.

2020 LONG-TERM INCENTIVE PLAN

Award of Restricted Stock Units. Pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the “Plan”) for Employees, Contractors, and Outside Directors of Enveric Biosciences, Inc., a Delaware corporation (the “Company”), the Company grants to

(the “Participant”)

EX-10.1·8-K·CIK 890821·ACC 0001493152-26-026364·Filed May 29, 2026, 16:13 ET

EX-10.1

Ellington Financial Inc.

ELLINGTON FINANCIAL INC.

2026 EQUITY INCENTIVE PLAN

1


TABLE OF CONTENTS

Page
Article I DEFINITIONS 4
1.01. Affiliate 4
1.02. Agreement 4
1.03. Award 4
1.04. Board 4
1.05. Bylaws 4
1.06. Cause 4
1.07. Certificate of Incorporation 4
1.08. Change in Control 5
1.09. Code 6
1.10. Committee 6
1.11. Common Stock 6
1.12. Common Unit 6
1.13. Company 6

EX-10.1·8-K·CIK 1411342·ACC 0001628280-26-039181·Filed May 29, 2026, 16:13 ET

EX-10.1

EXELIXIS, INC.

Exelixis, Inc.

2017 Equity Incentive Plan

Adopted by the Board of Directors: February 23, 2017 Amended by the Compensation Committee: March 22, 2017 Approved by the Stockholders: May 24, 2017 Amended by the Company: December 18, 2017 Amended by the Compensation Committee: March 18, 2020 Approved by the Stockholders: May 20, 2020 Amended by the Board of Directors: April 1, 2022 Approved by the Stockholders: May 25, 2022 Amended by the Board of Directors: April 6, 2026 Approved by the Stockholders: May 26, 2026

1.    General.

EX-10.1·8-K·CIK 939767·ACC 0000939767-26-000074·Filed May 29, 2026, 16:05 ET

EX-10.1

SILGAN HOLDINGS INC

FIRST AMENDMENT

TO THE

SILGAN HOLDINGS INC.

SECOND AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN

This First Amendment (this “Amendment”) to the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan (the “Plan”) is effective as of April 2, 2026 (the “Amendment Effective Date”), subject to the approval of this Amendment by the stockholders of Silgan Holdings Inc. (the “Company”) at the 2026 annual meeting of the stockholders of the Company.

WHEREAS, the Company maintains the Plan; and

WHEREAS, the Company considers it in the best interests of the Company to amend the Plan as set forth below.

NOW, THEREFORE, pursuant to Section 27(b) of the Plan, the Plan is hereby amended, effective as of the Amendment Effective Date, as follows:

1.Amendment to add Amendment Effective Date. Section 2(k) of the Plan is hereby amended and restated in its entirety to read as follows:

EX-10.1·8-K·CIK 849869·ACC 0001628280-26-039148·Filed May 29, 2026, 16:05 ET

Exhibit 10.1

NU SKIN ENTERPRISES, INC.

AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN

Stockholder Approval: May 28, 2026

Expiration Date: May 28, 2036


Nu Skin Enterprises, Inc. (the “Company”), a Delaware corporation, hereby establishes and adopts the following Amended and Restated 2024 Omnibus Incentive Plan.

1 PURPOSE OF THE PLAN

The purpose of the Plan is to assist the Company and its Subsidiaries in attracting and retaining selected individuals to serve as employees, directors, consultants and/or advisors who are expected to contribute to the Company’s success and to achieve long-term objectives that will benefit stockholders of the Company through the additional incentives inherent in the Awards hereunder.

2 DEFINITIONS

EX-10.1·8-K·CIK 1021561·ACC 0001140361-26-023312·Filed May 29, 2026, 16:05 ET

EX-10.1

TAP REAL ESTATE TECHNOLOGIES, INC.

Exhibit 10.1

FIRST ADDENDUM TO OPTION TO PURCHASE AGREEMENT

Zermatt Resort - Midway, Utah

Option Period Extension

This First Addendum to Option to Purchase Agreement (this “Addendum”) is entered into effective as of May 22, 2026, by and between Wasatch Springs Management Holdings, LLC, a Utah limited liability company (“Seller”), and TAP Real Estate Technologies, Inc., a Delaware corporation (“Option Holder”).

RECITALS

A. Seller and Option Holder entered into that certain Option to Purchase Agreement dated March 24, 2026 (the “Agreement”) relating to the Zermatt Resort located in Midway, Utah.
B. Section 3 of the Agreement provides that the Option shall remain in effect for a period of sixty (60) days from the Effective Date and that “Option Holder and Seller, by mutual agreement, may extend the Option Period as necessary.”
C. Seller and Option Holder desire to mutually extend the Option Period as set forth herein.

EX-10.1·8-K·CIK 1119190·ACC 0001493152-26-026350·Filed May 29, 2026, 16:05 ET

EXHIBIT 10.1

Ivanhoe Electric Inc.

Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.

Execution Version

Agreement between Mesa Cobre and Global TBM Company dba Robbins for the Purchase, Supply, Transport, Assembly, Testing, and Commissioning of a Tunnel Boring Machine and Associated Equipment

INDEX

Articles Description Page No.
1 Definitions and Interpretation 1
2 Scope of Work 3
3 Obligations of Robbins 3
4 Obligations of Mesa Cobre 3
5 Obligations of the Parties 4
6 Variations, Changes and Claims 4
7 Commencement and Time of Completion 6
8 Supply Conditions 6
9 Inspection 6
10 Price 7
11 Terms of Payment 7
12 Default of Robbins 8
13 Force Majeure 8
14 Default of Mesa Cobre 8
15 Termination for Convenience 9
16 Warranty by Robbins 8
17 Taxes 10
18 Termination 10

EX-10.1·8-K·CIK 1879016·ACC 0001104659-26-068231·Filed May 29, 2026, 16:05 ET

EX-10.1

ACADIA PHARMACEUTICALS INC

ACADIA PHARMACEUTICALS INC.

2024 EQUITY INCENTIVE PLAN

ADOPTED BY THE BOARD OF DIRECTORS: April 10, 2024

APPROVED BY THE STOCKHOLDERS: May 29, 2024

AMENDED BY THE BOARD OF DIRECTORS: April 14, 2026

APPROVED BY THE STOCKHOLDERS: May 29, 2026

1. GENERAL.

(a) Successor to and Continuation of Prior Plan. The Plan is the successor to and continuation of the Prior Plan. As of the Effective Date, (i) no additional awards could be granted under the Prior Plan or the 2023 Inducement Plan; (ii) the Prior Plan’s Available Reserve and 2023 Inducement Plan’s Available Reserve (plus any Prior Plans’ Returning Shares, as such term was defined prior to the Amendment Effective Date) became available for issuance pursuant to Awards granted under this Plan; (iii) all outstanding awards granted under the Prior Plan remained subject

EX-10.1·8-K·CIK 1070494·ACC 0001193125-26-248242·Filed May 29, 2026, 16:05 ET